Alexander Y. Tokman - 22 Aug 2022 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Alexander Tokman by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
22 Aug 2022
Net transactions value
+$5,200
Form type
4
Filing time
24 Aug 2022, 08:55:31 UTC
Previous filing
17 May 2022
Next filing
28 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NDRA Common Stock Purchase $5,200 +20,000 +15% $0.2600 152,857 22 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.